H. Demiraslan Et Al. , "Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia," MEDICAL MYCOLOGY , vol.55, no.5, pp.535-540, 2017
Demiraslan, H. Et Al. 2017. Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia. MEDICAL MYCOLOGY , vol.55, no.5 , 535-540.
Demiraslan, H., Atalay, M. A., Eren, E., Demir, K., Kaynar, L., Koç, A., ... Doğanay, M.(2017). Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia. MEDICAL MYCOLOGY , vol.55, no.5, 535-540.
Demiraslan, Hayati Et Al. "Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia," MEDICAL MYCOLOGY , vol.55, no.5, 535-540, 2017
Demiraslan, Hayati Et Al. "Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia." MEDICAL MYCOLOGY , vol.55, no.5, pp.535-540, 2017
Demiraslan, H. Et Al. (2017) . "Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia." MEDICAL MYCOLOGY , vol.55, no.5, pp.535-540.
@article{article, author={Hayati Demiraslan Et Al. }, title={Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia}, journal={MEDICAL MYCOLOGY}, year=2017, pages={535-540} }